Pharmaceutical composition for the treatment of dry eye and/or corneal/conjunctival disorders

摘要

The present invention provides a pharmaceutical composition for the treatment of dry eye and/or corneal -and conjunctival lesion which 5 comprises a recombinant human serum albumin produced by a recombinant yeast obtained by transforming a yeast with a gene for human serum albumin. Further, the present invention provides a method for the treatment of dry eye and/or corneal and conjunctival lesion, which comprises administering an effective amount of a recombinant human serum albumin produced by a recombinant yeast obtained by transforming a yeast with a gene for human serum albumin to a subject in need of the treatment of eye and/or corneal and conjunctival lesion.